Cargando…

Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease

BACKGROUND: In recent years, many studies focused on the association between the neutrophil-to-lymphocyte ratio (NLR) and the risk of intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (rKD), with inconsistent results. Therefore, we aimed to investigate the role of NLR as a biomarker in de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Gang, Yue, Peng, Ma, Fan, Zhang, Yi, Zheng, Xiaolan, Li, Yifei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015653/ https://www.ncbi.nlm.nih.gov/pubmed/32028387 http://dx.doi.org/10.1097/MD.0000000000018535

Ejemplares similares

Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as markers of stable ischemic heart disease in diabetic patients: An observational study
por: Joshi, Amey, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
por: Chen, Yongbing, et al.
Publicado: (2019)

Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio
por: Lu, Yuyao, et al.
Publicado: (2022)

A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease
por: Takeshita, Seiichiro, et al.
Publicado: (2017)

Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?—Current evidence based on a meta-analysis
por: Zheng, Xiaolan, et al.
Publicado: (2021)

Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction
por: Wang, Qian, et al.
Publicado: (2017)

A new marker of short-term mortality and poor outcome in patients with acute ischemic stroke: Mean platelet volume-to-lymphocyte ratio
por: Wu, Fan, et al.
Publicado: (2022)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease
por: Muto, Taichiro, et al.
Publicado: (2019)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

miRNAs as biomarkers for diagnosis of heart failure: A systematic review and meta-analysis
por: Yan, Hualin, et al.
Publicado: (2017)

Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study
por: Lan, Yinle, et al.
Publicado: (2020)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Lee, Sang Min, et al.
Publicado: (2014)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)

Coronary sequelae of Kawasaki disease treated with rotational atherectomy and drug coated balloon: A case report
por: Shi, Yongfeng, et al.
Publicado: (2020)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Relationship between monocyte/lymphocyte ratio and non-culprit plaque vulnerability in patients with acute coronary syndrome: An optical coherence tomography study
por: Zhang, Ting-yu, et al.
Publicado: (2020)

Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study
por: Wang, Yaochen, et al.
Publicado: (2021)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Can neutrophil-to-lymphocyte ratio predict cardiac involvement in kawasaki disease?
por: Gücenmez, Özge Altuğ, et al.
Publicado: (2014)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
por: Lee, Taek Jin, et al.
Publicado: (2008)

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Chen, Chih-Jen, et al.
Publicado: (2012)

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
por: Xie, Tian, et al.
Publicado: (2017)

Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease
por: Chen, Xi, et al.
Publicado: (2022)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

The Association Between Glycosylation of Immunoglobulin G and Hypertension: A Multiple Ethnic Cross-Sectional Study
por: Wang, Youxin, et al.
Publicado: (2016)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
por: Lee, Hye Young, et al.
Publicado: (2016)

Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease
por: Jun, Jae Sung, et al.
Publicado: (2017)

Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data
por: Lam, Jonathan Y., et al.
Publicado: (2023)

Neutrophil to Lymphocyte Ratio as a Biomarker for Predicting the Coronary Artery Abnormality in Kawasaki Disease: A Meta-Analysis
por: Sarejloo, Shirin, et al.
Publicado: (2022)

Diagnostic significance of circulating miRNAs in Kawasaki disease in China: Current evidence based on a meta-analysis
por: Zheng, Xiaolan, et al.
Publicado: (2021)

Poor efficacy of intravenous thrombolysis in de Winter pattern: A case report
por: Xiao, Hao, et al.
Publicado: (2023)

Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease: A preliminary, single-center, case–control study
por: Lin, Jing, et al.
Publicado: (2018)

Treatment of longitudinal stent compression under intravenous ultrasound guidance: A case report
por: Si, Daoyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qqjeebrhidgbgj2v6ifk3ru341